Paul L Berns Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

JAZZ Quotes by TradingView

Paul L Berns is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 8,290 shares of JAZZ, which is worth approximately $1.05 Million. The most recent transaction as insider was on Aug 05, 2021, when has been sold 1,450 shares (Ordinary Shares) at a price of $154.0 per share, resulting in proceeds of $223,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.29K
0% 3M change
0% 12M change
Total Value Held $1.05 Million

PAUL L BERNS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2021
SELL
Open market or private sale
$223,300 $154.0 p/Share
1,450 Reduced 14.89%
8,290 Ordinary Shares
Nov 04 2020
SELL
Open market or private sale
$699,944 $149.21 p/Share
4,691 Reduced 32.51%
9,740 Ordinary Shares
Nov 02 2020
BUY
Exercise of conversion of derivative security
-
4,691 Added 24.53%
14,431 Ordinary Shares

Also insider at

UBX
Unity Biotechnology, Inc. Healthcare
EQRX
EQRx, Inc. Healthcare
Director
NMRA
Neumora Therapeutics, Inc.
PLB

Paul L Berns

Director
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JAZZ